GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Microport Endovascular Medtech Co Ltd (SHSE:688016) » Definitions » Asset Impairment Charge

Shanghai Microport Endovascular Medtech Co (SHSE:688016) Asset Impairment Charge : ¥0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Microport Endovascular Medtech Co Asset Impairment Charge?

Shanghai Microport Endovascular Medtech Co's Asset Impairment Charge for the three months ended in Sep. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0 Mil.

Shanghai Microport Endovascular Medtech Co Asset Impairment Charge Historical Data

The historical data trend for Shanghai Microport Endovascular Medtech Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Microport Endovascular Medtech Co Asset Impairment Charge Chart

Shanghai Microport Endovascular Medtech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial - - - - -

Shanghai Microport Endovascular Medtech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Microport Endovascular Medtech Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shanghai Microport Endovascular Medtech Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Shanghai Microport Endovascular Medtech Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Microport Endovascular Medtech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Microport Endovascular Medtech Co Ltd (SHSE:688016) » Definitions » Asset Impairment Charge
Comparable Companies
SZSE:301363 SHSE:600055 SZSE:002901 SZSE:300482 SHSE:688161 SHSE:688139 SHSE:600587 SZSE:300298 SHSE:688351 SHSE:688198 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 1 Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 201318
Website
http://www.endovastec.com
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.
Executives
Lu Hong Jie Core technical personnel

Shanghai Microport Endovascular Medtech Co Headlines

No Headlines